Aemetis, Inc. is a biotechnology company. The Company has engineered bacterium capable of converting whole plant materials into sugars that can then be used to make a range of commercially products in the biochemical and biofuels industries.

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

S-3 | Registration statement for specified transactions by certain issuers

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Aemetis (AMTX US)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

S-3 | Registration statement for specified transactions by certain issuers

Current Report (Form 8-K | Period ending 2024-08-01)

Current Report (Form 8-K | Period ending 2024-05-29)

Current Report (Form 8-K | Period ending 2024-05-09)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)